Profile
ACER VRTX REGN ALNY SGEN ARGX
Company Name Acer Therapeutics Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap - $117.98B $58.16B $43.28B $43.15B $34.40B
Employees 0.03K 6.10K 15.16K 2.23K 3.26K 1.60K
CEO Christopher Schelling Reshma Kewalramani FASN, Leonard S. Schleifer Yvonne L. Greenstreet David R. Epstein Timothy Van Hauwermeiren EMBA,
Ratings
ACER VRTX REGN ALNY SGEN ARGX
Quant Rating Score 3 2 4 1 3 2
Quant Rating Neutral Sell Buy Strong Sell Neutral Sell
Trading
ACER VRTX REGN ALNY SGEN ARGX
Last Close $0.6601 $469.55 $547.93 $322.81 $228.74 $577.92
High 52 $0.9 $516.74 $1201.76 $331.91 $228.74 $671.75
Low 52 $0.66 $396.64 $482.92 $224.58 $228.74 $461.01
Price vs. 52 Week High -26.66 % -9.13 % -54.41 % -2.74 % 0 % -13.97 %
Price vs. 52 Week Low 0.02 % 18.38 % 13.46 % 43.74 % 0 % 25.36 %
Total Return
ACER VRTX REGN ALNY SGEN ARGX
1 Month Return 0 % 6.24 % 7.65 % 4.54 % 0 % 6.88 %
3 Month Return 0 % -4 % -2.7 % 37.62 % 0 % -3.07 %
6 Month Return 0 % 11.27 % -19.61 % 31.08 % 0 % -9.77 %
9 Month Return -26.66 % -5.85 % -45.09 % 8.8 % 0 % 6.37 %
YTD Return 0 % 16.6 % -23.08 % 37.18 % 0 % -6.03 %
1 Year Return 0 % -3.85 % -49.53 % 34.49 % 0 % 24.71 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACER VRTX REGN ALNY SGEN ARGX
Dividend Yield Percentage (TTM) - - 0.32 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -176.74 % -3.53 % 3.85 % -1.49 % -5.87 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
ACER VRTX REGN ALNY SGEN ARGX
Asset Growth -67.94 % -0.87 % 36.55 %
Gross Profit Growth -100 % 10.25 % 77.08 %
Revenue Growth -100 % 11.66 % 78.6 %
Revenue 3 Year - 45.6 % 275.84 %
Revenue 5 Year 100 % 163.93 % 1701.04 %
Revenue 10 Year - 1632.15 % 5950.81 %
EBIT Growth - -93.69 % 128.87 %
Net Income Growth -89.16 % -114.8 % 382.34 %
Net Income 3 Yeari Growth Per Share 38.25 % -122.89 % 274.39 %
Net Income 5 Yeari Growth Per Share 54.01 % -145.38 % 396.61 %
Net Income 10 Yeari Growth Per Share 98.44 % 33.84 % 938.02 %
Operating Income Growth -54.34 % -106.08 % 94.91 %
Operating Cash Flow Growth (CFG) -22323.93 % -113.93 % 80.31 %
Operating 3 Year CFG 34.38 % -118.65 % 88.36 %
Operating 5 Year CFG 49.71 % -131.3 % -135.21 %
Operating 10 Year CFG 98.3 % 12.43 % -64 %
EPS Growth -71.84 % -114.8 % 369.77 %
EPS Diluted Growth -71.84 % -114.97 % 347.67 %
Book Value Per Share -780.02 % -6.59 % 28.16 %
Share Holder 3 Year Equity Growth Per Share -158.4 % 62.6 % 85.14 %
Share Holder 5 Year Equity Growth Per Share -117.58 % 168.85 % 200.53 %
Share Holder 10 Year Equity Growth Per Share -102.91 % 1265.7 % 1039.11 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth 2912.5 % 116.42 % 95.27 %
Free Cash Flow Growth -15924.54 % -124.1 % 67.46 %
Updated On 31 Dec 2022 31 Dec 2024 31 Dec 2024
Profitability
ACER VRTX REGN ALNY SGEN ARGX
Gross Profit Margin TTM - 86.03 % 84.94 % 86.01 % 79.1 % 46.33 %
Return on Assets TTM -239.68 % -4.32 % 11.98 % -6.4 % -16.61 % 13.45 %
Return on Equity TTM 301.44 % -6.25 % 14.77 % -509.33 % -20.8 % 16.83 %
Return on Capital Employed TTM 335.92 % -3.89 % 11.35 % -3.68 % -21.46 % -0.5 %
Net Income Per EBT TTM 106.19 % 329.41 % 90.27 % 75.89 % 101.33 % 25990.14 %
EBT Per Ebit TTM 106.59 % 40.44 % 129.3 % 308.03 % 98.26 % -11.64 %
EBIT Per Revenue TTM - -6.69 % 27.37 % -4.91 % -31.24 % -1.24 %
Cash Flow To Debt Ratio TTM -254.98 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Receivables Turnover TTM - 6.15 2.53 5.62 3.91 2.46
Payables Turnover TTM - 3.49 3.01 3.37 1.97 2.39
Inventory Turnover TTM - 1.14 0.66 5.01 0.96 2.93
Fixed Asset Turnover TTM - 421.34 % 300.07 % 337.41 % 665.41 % 4929.48 %
Asset Turnover TTM - 48.51 % 37.52 % 55.72 % 53.41 % 35.83 %
Operating Cash Flow Per Share TTM -1.92 -3.82 37.05 -0.35 -2.46 -1.07
Free Cash Flow Per Share TTM -1.93 -4.9 28.3 -0.58 -2.88 -1.09
Cash Per Share TTM 14.77 % 2413.86 % 7825.12 % 2024.29 % 939.52 % 4688.94 %
Operating Cash Flow Sales Ratio TTM - -8.83 % 28.06 % -1.92 % -23.12 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.57 % 128.33 % 76.4 % 167.11 % 117.04 % 102.26 %
Cash Flow Coverage Ratios TTM -254.98 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Price To Free Cash Flows Ratio TTM - -93.78 19.26 -574.08 -81.26 -443.33
Price To Operating Cash Flows Ratio TTM -0.34 -120.39 14.79 -954.11 -93.1 -526.76
Price Cash Flow Ratio TTM -0.34 -120.39 14.79 -954.11 -93.1 -526.76
Income Statement (TTM)
ACER VRTX REGN ALNY SGEN ARGX
Revenue $0B $11.02B $14.2B $2.25B $1.96B $2.19B
Gross Profit $0B $9.49B $12.23B $1.92B $1.55B $1.96B
Gross Profit Ratio 0% 86.11% 86.13% 85.62% 79.1% 89.62%
EBITDA $-0.02B $0.49B $5.32B $-0.18B $-0.62B $0.11B
Net Income $-0.03B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
EPS Diluted -1.77 -2.08 38.34 -2.16 -3.3 12.78
Balance Sheet (MRQ)
ACER VRTX REGN ALNY SGEN ARGX
Long Term Debt $0.01B $1.66B $1.98B $0B $0.04B $0.03B
Total Liabilities $0.03B $6.12B $8.41B $4.17B $0.87B $0.7B
Total Equity $-0.02B $16.41B $29.35B $0.07B $2.8B $5.5B
Total Investments $0B $6.65B $15.42B $1.73B $1.42B $1.93B
Total Debt $0.01B $1.75B $2.7B $1.3B $0.04B $0.04B
Total Assets $0.01B $22.53B $37.76B $4.3B $3.67B $6.2B
Cash Flow Statement (TTM)
ACER VRTX REGN ALNY SGEN ARGX
Net Income $-0.03B $-0.54B $4.41B $-0.28B $-0.61B $-0.02B
Inventory $0B $-0.52B $-0.62B $0.01B $-0.23B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.03B $-0.49B $4.42B $-0.01B $-0.45B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.03B $-0.08B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 39.425
AARD Aardvark Therapeutics, Inc. Common Stock 12.03
ABCL AbCellera Biologics Inc. 3.895
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 6.63
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.5
ABPWW 0.0225
ABSI Absci Corporation 2.885
ABUS Arbutus Biopharma Corporation 3.135
ABVC ABVC BioPharma, Inc. 3.57
ABVX Abivax SA American Depositary Shares 10.32
ACAD ACADIA Pharmaceuticals Inc. 22.57
ACET Adicet Bio, Inc. 0.7911
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.75
ACIU AC Immune SA 2.07
ACLX Arcellx, Inc. 70.95
ETFs With Exposure to ACER
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 309.245
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 137.385
IWC iShares Micro-Cap ETF 0.0034 134.365
ACSG Xtrackers MSCI ACWI ex USA ESG Leaders Equity ETF 0.03 33.28
Unlock